Medicalgorithmics

Medicalgorithmics P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Medicalgorithmics (MDG.WA) as of Oct 17, 2026 is -153.76. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -14.25 — a change of 978.98% (lower).

P/FCF

-153.76

YoY

978.98%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Medicalgorithmics is 2025 -153.76 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Medicalgorithmics was 2024 -14.25 . It decreases by 978.98% lower compared to the previous year.

The Medicalgorithmics P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
8.69 PLN
Jan 1, 2019
69.09 PLN
Jan 1, 2020
-36.65 PLN
Jan 1, 2021
-14.69 PLN
Jan 1, 2022
-54.35 PLN
Jan 1, 2023
-29.49 PLN
Jan 1, 2024
-14.25 PLN
Jan 1, 2025
-153.76 PLN
The Medicalgorithmics P/FCF history
YEARP/FCFYoY
-153.76+978.98%
-14.25-51.68%
-29.49-45.74%
-54.35+269.98%
-14.69-59.92%
-36.65-153.05%
69.09+695.10%
8.69-124.39%
-35.62-392.72%
12.17-45.70%
22.41-155.06%
-40.71—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medicalgorithmics Stock analysis

What does Medicalgorithmics do? Medicalgorithmics SA is a health care company based in Warsaw, Poland, with a focus on developing mobile electrocardiogram and arrhythmia diagnostic technology. The company has 122 employees and went public on November 9, 2011. Its primary product, PocketECG, enables remote monitoring of cardiac disorders and arrhythmia diagnosis, as well as monitoring of heart conditions and supporting clinical drug trials for cardiac safety. Medicalgorithmics SA also provides information technology and biotechnology services, along with conducting scientific research and development in the natural sciences. The company operates through subsidiaries including MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC. It is listed on the Warsaw Stock Exchange under the ticker MDG.WA and has an ISIN of PLMDCLG00015. The company's activities include the development of tele-rehabilitation cardiology devices, software for optimizing hospital workflows, and systems for remote electrocardiography (ECG) description. Medicalgorithmics SA is engaged in the health care sector, specifically within the health care industry, serving both clinical and research applications in cardiology. Medicalgorithmics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicalgorithmics stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Medicalgorithmics is -153.76 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Medicalgorithmics changed from -14.25 to -153.76, representing a 978.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Medicalgorithmics since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Medicalgorithmics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Medicalgorithmics

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Medicalgorithmics